bluebird bio Inc/ US09609G1004 /
29/05/2024 22:00:00 | Chg. -0.0387 | Volume | Bid01:28:38 | Demandez à01:28:38 | Haut | Bas |
---|---|---|---|---|---|---|
0.9014USD | -4.12% | 7.39 Mio. Chiffrre d'affaires: 6.52 Mio. |
0.9000Bid taille: 100 | 0.9153Ask la taille: 1,000 | 0.9299 | 0.8900 |
GlobeNewswire
09:01
Persistent Systems Selects Zscaler to Launch Technology Modernization and Renewable Energy Initiativ...
GlobeNewswire
09:00
Curium Announces First Commercial Doses in France of Pylclari® – an Innovative 18F-Psma Pet Tracer I...
GlobeNewswire
09:00
Green Bioactives Reports Remarkable Cognitive Benefits of its Newly Launched Memory-boosting Nutrace...
GlobeNewswire
08:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
08:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
08:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
08:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
08:30
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page